Dermolab Pharma Ltd.
FDA inspection history in Sainte-Julie, Canada, 2023
- 1
- Form 483
Every document, by year
- Form 483
2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2023One Form 483, at Sainte-Julie, Canada.
Cited most
Across all Dermolab Pharma observations on file
- 21 CFR 211.100(a)Written procedures; deviations1
- 21 CFR 211.180(e)(1)General requirements1
- 21 CFR 211.192Production record review1
- 21 CFR 211.22(a)Responsibilities of quality control unit1
The complete Dermolab Pharma file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Sainte-Julie, Canada
One Form 483 · 2023 · 4 observations
Latest: Form 483, Oct 13, 2023 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-10-13 | 483 Form 483 | Sainte-Julie, Canada | 4 | $99 |
Investigators on these documents
FEI number 3003011816 · most recent document Oct 13, 2023
About Dermolab Pharma Ltd.
How many FDA Form 483s has Dermolab Pharma Ltd. received?
FDA Intel has 1 Form 483 on file for Dermolab Pharma Ltd.; the most recent is dated Oct 13, 2023.
When was Dermolab Pharma Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Dermolab Pharma Ltd. is a Form 483 dated Oct 13, 2023, for the site in Sainte-Julie, Canada.
What did FDA cite at Dermolab Pharma Ltd.?
The regulations cited most in the observations on file for Dermolab Pharma Ltd. are 21 CFR 211.100(a) (Written procedures; deviations), 1 time; 21 CFR 211.180(e)(1) (General requirements), 1 time; 21 CFR 211.192 (Production record review), 1 time.